|

Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

San Diego, United States, November seventeenth, 2025, Chainwire

LITS Is the First and Only US Publicly Traded Company to Gain Institutional Exposure to LTC, Holding 929,548 LTC Tokens.

Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”) right now reported outcomes for its first quarter ended September 30, 2025, and highlighted current company occasions associated to the Company’s digital asset treasury technique in addition to its pharmaceutical operations.

“Our first quarter was extremely profitable for LITS. We launched our digital treasury technique, positioning ourselves because the main public holder of LTC, and up to date our company profile to bolster our new focus,” Board Member Charlie Lee mentioned. “We not too long ago celebrated Litecoin’s 14th anniversary and its unblemished monitor report of reliability and uptime. LITS gives buyers the one US publicly traded firm to realize institutional publicity to Litecoin, each for portfolio diversification and long-term worth.”

“Fiscal yr 2026 will showcase the outcomes of the transformative steps taken by Lite Strategy. Since the beginning of our strategic options course of in fiscal yr 2025, we’ve got prioritized maximizing the worth of our property for stockholders. Starting with the profitable sale of our scientific asset, ME-344 (now often known as WE-868), presently being developed for adults with weight problems at Aardvark Therapeutics, and persevering with by way of the shut of our $100 million PIPE providing in July 2025 that kicked off our Litecoin digital asset treasury technique within the first quarter of this fiscal yr,” mentioned Jay File, CEO, CFO.

First Quarter Fiscal Year 2026 and Recent Highlights

  • Raised $100 million in combination gross proceeds, commencing the Company’s long-term strategic plan with Litecoin as a digital asset treasury reserve asset.
  • Officially grew to become the primary U.S.-listed public firm to undertake Litecoin as a major reserve asset with the acquisition of 929,548 Litecoin (LTC) tokens, implementing a brand new technique constructed on a digital asset infrastructure and long-term capital innovation.
  • Entered into a strategic partnership with GSR, a number one crypto funding agency, to information LITS’ digital asset treasury technique, guaranteeing strong governance, execution, and market experience.
  • Brought on world-class board members, Charlie Lee, creator of Litecoin, and Joshua Riezman, U.S. Chief Strategy Officer at GSR.
  • Rebranded from MEI Pharma to Lite Strategy, together with altering the Company’s company title and NASDAQ Stock Market ticker from MEIP to LITS, and unveiling a brand new company emblem and web site. The rebranding underscores the Company’s dedication to constructing a long-term company technique round LTC as its major reserve asset.
  • In October introduced a $25 million share repurchase program, advancing LITS from the preliminary part of Litecoin accumulation to lively capital market operations and permitting LITS to leverage our practically 1 million LTC treasury – a key differential from passive funding constructions like exchange-traded funds.

“As we progress additional into fiscal yr 2026, we proceed to judge our scientific property together with the graduation of pre-clinical research with voruciclib in non-oncology illness indications for potential licensing to 3rd events, and pursuing licensing or sale alternatives with zandelisib,” mentioned Jay File. “We will contemplate alternatives to deploy our not too long ago introduced $25 million inventory buyback program till our low cost to NAV is normalized. We look ahead to executing on all our company aims as we progress by way of fiscal yr 2026.”

As of September 30, 2025, the Company had $12.21 million in working capital with no excellent debt.

To study extra about Lite Strategy, go to the Company’s homepage at https://litestrategy.com.

To study extra about Litecoin and its function in Lite Strategy’s treasury, go to the About Litecoin web page at https://litestrategy.com/about-litecoin/.

To study extra concerning the transaction with Aardvark, learn the Form 8-Ok submitting at https://investor.meipharma.com/sec-filings/sec-filing/8-k/0000950170-24-117406.

For present holdings and associated Company metrics, go to Lite Strategy’s dashboard at https://litestrategy.com/dashboard/.

About Lite Strategy, Inc. (LITS)

Lite Strategy, Inc. (NASDAQ: LITS) is the primary U.S. publicly traded firm to undertake Litecoin as its major reserve asset. Formerly MEI Pharma, the Company has expanded its enterprise mannequin past its portfolio of drug candidates to deal with pioneering institutional-grade digital asset treasury methods, in partnership with main innovators throughout blockchain, finance, and expertise.

Forward-Looking Statements

Certain data contained on this press launch that aren’t historic in nature are “forward-looking statements” inside the that means of the “protected harbor” provisions of the Private Securities Litigation Reform Act of 1995 together with, with out limitation, statements concerning our future actions, potential merchandise and actions, future efficiency or outcomes. You ought to be conscious that our precise outcomes may differ materially from these contained within the forward-looking statements, that are primarily based on administration’s present expectations and are topic to a quantity of dangers and uncertainties, together with, however not restricted to, threat regarding with the ability to repurchase our shares available in the market on enticing phrases or in any respect, sustaining our present itemizing on Nasdaq, our potential to retain and entice senior administration and different key staff, fluctuations available in the market value of LTC and any related impairment expenses that we might incur in consequence of a lower available in the market value of LTC beneath the worth at which LTC is carried on our stability sheet, adjustments within the accounting remedy regarding our LTC holdings, our potential to attain worthwhile operations, authorities regulation of cryptocurrencies and on-line betting, adjustments in securities legal guidelines or laws, buyer acceptance of new merchandise and providers together with our LTC treasury technique, our potential to make the most of our repurchase program, the demand for our merchandise and our clients’ financial situation, the affect of aggressive merchandise and pricing, our proprietary rights, common financial circumstances and different threat elements detailed in our annual report and different filings with the SEC. We don’t intend to replace any of these elements or to publicly announce the outcomes of any revisions to those forward-looking statements.

Contact

CEO, CFO
Justin J. File
Lite Strategy, Inc.
investor@litestrategy.com
858-369-7199

The put up Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations appeared first on Metaverse Post.

Similar Posts